Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5180238
Max Phase: Preclinical
Molecular Formula: C22H13ClF3NO
Molecular Weight: 399.80
Associated Items:
ID: ALA5180238
Max Phase: Preclinical
Molecular Formula: C22H13ClF3NO
Molecular Weight: 399.80
Associated Items:
Canonical SMILES: FC(F)(F)c1ccc(Oc2cc(-c3cccc(Cl)c3)nc3ccccc23)cc1
Standard InChI: InChI=1S/C22H13ClF3NO/c23-16-5-3-4-14(12-16)20-13-21(18-6-1-2-7-19(18)27-20)28-17-10-8-15(9-11-17)22(24,25)26/h1-13H
Standard InChI Key: KAWMFDRCMJGBDH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 399.80 | Molecular Weight (Monoisotopic): 399.0638 | AlogP: 7.37 | #Rotatable Bonds: 3 |
Polar Surface Area: 22.12 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 3.84 | CX LogP: 7.15 | CX LogD: 7.15 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.36 | Np Likeness Score: -1.17 |
1. Nahide PD, Alba-Betancourt C, Chávez-Rivera R, Romo-Rodríguez P, Solís-Hernández M, Segura-Quezada LA, Torres-Carbajal KR, Gámez-Montaño R, Deveze-Álvarez MA, Ramírez-Morales MA, Alonso-Castro AJ, Zapata-Morales JR, Ruiz-Padilla AJ, Mendoza-Macías CL, Meza-Carmen V, Cortés-García CJ, Corrales-Escobosa AR, Núñez-Anita RE, Ortíz-Alvarado R, Chacón-García L, Solorio-Alvarado CR.. (2022) Novel 2-aryl-4-aryloxyquinoline-based fungistatics for Mucor circinelloides. Biological evaluation of activity, QSAR and docking study., 63 [PMID:35245665] [10.1016/j.bmcl.2022.128649] |
Source(1):